MedPath

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

Not Applicable
Completed
Conditions
Scleral Buckling
Interventions
Drug: standard post-operative topical drops
Drug: Timolol-dorzolamide (Glaucoma drops)
Registration Number
NCT01843920
Lead Sponsor
Jason Hsu, MD
Brief Summary

A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.

Detailed Description

A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration following Scleral Buckling and Pneumatic Retinopexy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Ability to provide written informed consent and comply with study assessments for the full duration of the study.
  • Have undergone eye surgery including scleral buckling or pneumatic retinopexy for treatment of retinal detachment other condition at the discretion of the investigator.
Exclusion Criteria
  • Prior surgery to treat glaucoma.
  • Current use of glaucoma eye drops.
  • Absence of a lens in the eye or presence of a lens implant in front of the iris (colored part of your eye).
  • Allergy or contraindication to any of the glaucoma drops being used in this study (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or emphysema), slow heart rate).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Post surgery without glaucoma dropsstandard post-operative topical dropsThis will be for the group that had gas duration surgery using SF6 (Sulfur Hexafluoride) or C3F8 (perfluoropropane gas tamponade) and only uses the standard post-operative topical drops.
Post surgery with glaucoma dropsTimolol-dorzolamide (Glaucoma drops)This will be for the group that had gas duration surgery (using SF6 or C3F8). In addition to the standard post-operative topical drops, glaucoma drops, Timolol-dorzolamide (timolol 0.5%-dorzolamide 2%) will be given.
Post surgery with glaucoma dropsstandard post-operative topical dropsThis will be for the group that had gas duration surgery (using SF6 or C3F8). In addition to the standard post-operative topical drops, glaucoma drops, Timolol-dorzolamide (timolol 0.5%-dorzolamide 2%) will be given.
Primary Outcome Measures
NameTimeMethod
Complete Resolution of Intraocular Gas BubbleFollowing surgery, until gas bubble is gone. Up to 2 months.

This will be reported by the patient when they see/feel the gas bubble disappear.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Return of Intraocular Pressure to Normal LevelsMonth 2

Number of participants with a normal intraocular pressure of 10-21 mm Hg at the Month 2 visit

Trial Locations

Locations (1)

Mid Atlantic Retina- Wills Eye Institute

🇺🇸

Philadelphia, Pennsylvania, United States

Mid Atlantic Retina- Wills Eye Institute
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.